Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo biloba in mild cognitive impairment patients with dizziness
KCT0010472Phase 4Recruiting
- Sponsor
- SK Chemicals
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ginkgo biloba extract in Mild Cognitive Impairment (MCI), sponsored by SK Chemicals. Started Apr 2024; status: recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on KCT0010472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010472.